Camden Capital »

iShares NASDAQ Biotechnology Index shares owned by Camden Capital

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Camden Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $365k 2.5k 144.36
2025-06-30 $319k 2.5k 126.49
2025-03-31 $319k 2.5k 127.88
2024-12-31 $454k 3.4k 132.22
2024-06-30 $301k 2.2k 137.27
2024-03-31 $389k 2.8k 137.23
2023-12-31 $466k 3.4k 135.86
2022-09-30 $511k 4.4k 116.96

More positions owned by Camden Capital

NVIDIA Corporation Put Option (NVDA)
Onemain Holdings (OMF)
Citigroup Com New (C)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ge Aerospace Com New (GE)
Apple (AAPL)
Micron Technology (MU)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Microsoft Corporation (MSFT)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Flagstar Financial Com New (FLG)
PNC Financial Services (PNC)

View all positions for Camden Capital

Top funds holding iShares NASDAQ Biotechnology Index

Morgan Stanley
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
UBS Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Commerce Bank N A
Wells Fargo & Company
Royal Bank of Canada
Calamos Advisors
Jane Street
Citadel Advisors
Leucadia National Corporation
Barclays

View all funds holding iShares NASDAQ Biotechnology Index